KRH Receives Top Site Award for Cardiology Clinical Trial
Kalispell Regional Healthcare’s research branch, Glacier View Research Institute has been awarded a Heart Failure Society of America (HSFA) Top Site award for its outstanding performance in the METEORIC-Heart Failure clinical trial. Congratulations to the skilled research and medical team consisting of: Eve Gillespie, MD; Austine Siomos, MD; Robert Confessore, PhD; Amy Zupicich, APRN; Pamela Smith, APRN, Lucia Kufa MS, CCRC; Joanne Smith; and Brandy Anderson, CCRC.
This clinical research study assesses the effect of a drug to see if it can improve the heart’s strength so that patients with heart failure may have increased ability to exercise and be active.
Heart failure is a chronic and progressive condition in which the heart struggles to pump enough oxygen around the body. Put simply, the heart cannot keep up with its workload. Although treatments exist for heart failure, they may not work well enough for everyone and many people experience unpleasant side effects from taking them. Because of this, people with heart failure may have difficulty exercising or leading an active lifestyle. The study has 270 participants worldwide, who among other things are 18 to 85 years old, have a history of chronic heart failure and are receiving continuous treatment for it.
We would like to extend a special thank you to our patients who have chosen to enroll in this trial, and others happening at KRH.
Kalispell Regional Healthcare is proud to bring clinical trial access to patients in northwest Montana through its research branch Glacier View Research Institute, whose mission to offer cutting-edge treatment to patients. Glacier View Research Institute participates in research in many care and treatment areas such as cancer, cardiology, endocrinology, rheumatology, and COVID-19.
Clinical trials or clinical research studies are carefully designed scientific studies that test medications on groups of people. All studies have a specific focus, but generally they aim to answer questions about a drug like: how safe is it, how well—if at all—does it work, what should the dosing considerations be? All new drugs and treatments go through some type of clinical trial or study process before they are made available for patients.
To see which trials are currently happening at KRH, visit https://www.krh.org/krhc/services/research/open-to-enrollment-studies.